SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-14-374465
Filing Date
2014-10-17
Accepted
2014-10-17 09:01:02
Documents
10
Period of Report
2014-12-03
Effectiveness Date
2014-10-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A d795946ddef14a.htm DEF 14A 645078
2 GRAPHIC g795946g46r09.jpg GRAPHIC 13097
3 GRAPHIC g795946g55o77.jpg GRAPHIC 7272
4 GRAPHIC g795946g56t82.jpg GRAPHIC 5423
5 GRAPHIC g795946pc1a_new1.jpg GRAPHIC 40120
6 GRAPHIC g795946pc1bnew.jpg GRAPHIC 45507
7 GRAPHIC g795946pc1c.jpg GRAPHIC 4380
8 GRAPHIC g795946pc1d.jpg GRAPHIC 4419
9 GRAPHIC g795946pc1e.jpg GRAPHIC 14447
10 GRAPHIC g795946pc1f.jpg GRAPHIC 18468
  Complete submission text file 0001193125-14-374465.txt   858546
Mailing Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 000-50484 | Film No.: 141160745
SIC: 2834 Pharmaceutical Preparations